RPRX logo

Royalty Pharma plc (RPRX) Cost Of Goods Sold

Annual Cost Of Goods Sold:

N/A
December 31, 2024

Summary

  • RPRX annual cost of goods sold is not available.

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

RPRX Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

$33.27M
RPRX annual cost of goods sold is currently at an all-time high

3-Year Low

$5.67M
RPRX annual cost of goods sold is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RPRX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 10, 2026
RPRX next annual earnings announcement is scheduled for Feb 10, 2026

OtherRPRXincome statement metrics

Annual Total Expenses

$1.40B
RPRX annual total expenses is $1.40 billion

Annual Operating Expenses

-$1.29B
RPRX annual total operating expenses is -$1.29 billion

Annual SG&A

$0.00
RPRX annual SG&A is $0.00

Annual D&A

$0.00
RPRX annual D&A is $0.00

Quarterly Cost Of Goods Sold:

$1.28M(NaN%)
September 30, 2025

Summary

  • As of today, RPRX quarterly cost of goods sold is $1.28 million
  • RPRX quarterly cost of goods sold is now -78.72% below its all-time high of $6.00 million, reached on December 31, 2021.

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

RPRX Quarterly Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

49.73%
RPRX quarterly cost of goods sold is higher than 49.73% of companies in Healthcare sector

Range

All-Time High

$6.00M
RPRX quarterly cost of goods sold is currently -78.72% below its historical high of $6.00 million

3-Year Low

$1.28M
RPRX quarterly cost of goods sold is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
RPRX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 10, 2026
RPRX next earnings announcement is scheduled for Feb 10, 2026

OtherRPRXincome statement metrics

Quarterly Total Expenses

$321.07M
RPRX quarterly total expenses is $321.07 million

Quarterly Operating Expenses

$180.86M
RPRX quarterly total operating expenses is $180.86 million

Quarterly SG&A

$0.00
RPRX quarterly SG&A is $0.00

Quarterly D&A

$1.28M
RPRX quarterly D&A is $1.28 million

TTM Cost Of Goods Sold:

$1.28M(NaN%)
September 30, 2025

Summary

  • As of today, RPRX TTM cost of goods sold is $1.28 million
  • RPRX TTM cost of goods sold is now -89.06% below its all-time high of $11.67 million, reached on March 31, 2022.

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

RPRX TTM Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

33.33%
RPRX TTM cost of goods sold is higher than 33.33% of companies in Healthcare sector

Range

All-Time High

$11.67M
RPRX TTM cost of goods sold is currently -89.06% below its historical high of $11.67 million

3-Year Low

$1.28M
RPRX TTM cost of goods sold is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
RPRX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 10, 2026
RPRX next earnings announcement is scheduled for Feb 10, 2026

OtherRPRXincome statement metrics

Annual Total Expenses

$1.40B
RPRX annual total expenses is $1.40 billion

Annual Operating Expenses

-$1.29B
RPRX annual total operating expenses is -$1.29 billion

TTM SG&A

$9.85B
RPRX TTM SG&A is $9.85 billion

TTM D&A

$1.28M
RPRX TTM D&A is $1.28 million

Cost Of Goods Sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

Annual Cost Of Goods Sold

-
RPRX annual cost of goods sold value is unknown

Annual Inventory

$0.00
RPRX annual inventory is $0.00

RPRX Cost Of Goods Sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year---
3Y3 Years---
5Y5 Years---

RPRX Cost Of Goods Sold Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat highat lowat highat low
5Y5-Year-78.7%at low-89.1%at low
All-TimeAll-Time-78.7%at low-89.1%at low

RPRX Cost Of Goods Sold History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.28M(-77.5%)
$1.28M(-89.1%)
Dec 2022
$5.67M
-
-
DateAnnualQuarterlyTTM
Mar 2022
-
$5.67M(-5.5%)
$11.67M(+94.5%)
Dec 2021
$23.00M(-30.9%)
$6.00M
$6.00M
Dec 2017
$33.27M
-
-

FAQ

  • What is the all-time high annual cost of goods sold for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly cost of goods sold?
  • What is the all-time high quarterly cost of goods sold for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM cost of goods sold?
  • What is the all-time high TTM cost of goods sold for Royalty Pharma plc?

What is the all-time high annual cost of goods sold for Royalty Pharma plc?

Royalty Pharma plc all-time high annual cost of goods sold is $33.27M

What is Royalty Pharma plc quarterly cost of goods sold?

The current quarterly cost of goods sold of RPRX is $1.28M

What is the all-time high quarterly cost of goods sold for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly cost of goods sold is $6.00M

What is Royalty Pharma plc TTM cost of goods sold?

The current TTM cost of goods sold of RPRX is $1.28M

What is the all-time high TTM cost of goods sold for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM cost of goods sold is $11.67M
On this page